Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Heart Failure|August 14, 2010
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpointsBenjamin D Horne, Heidi T May, Abdallah G Kfoury, et al.
American Heart Journal|September 19, 2021
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery diseaseTyson S Burnham, Heidi T May, Tami L Bair, et al.
Plos One|July 23, 2013
Repeated measurement of the intermountain risk score enhances prognostication for mortalityBenjamin D Horne, Donald L Lappé, Joseph B Muhlestein, et al.
American Heart Journal|March 8, 2017
Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalizationBenjamin D Horne, Deborah Budge, Andrew L Masica, et al.
Frontiers in Cardiovascular Medicine|September 8, 2023
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular eventsViet T Le, Stacey Knight, Jeramie D Watrous, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
The American Journal of Cardiology|September 23, 2008
Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiographyBenjamin D Horne, Heidi T May, Jeffrey L Anderson, et al.
JCI Insight|July 27, 2018
Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortalityBenjamin D Horne, Joseph B Muhlestein, Sterling T Bennett, et al.
Annals of Internal Medicine|September 24, 2004
Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication programJason M Lappé, Joseph B Muhlestein, Donald L Lappé, et al.
Circulation|March 21, 2012
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II)Jeffrey L Anderson, Benjamin D Horne, Scott M Stevens, et al.
Pageof 14